The Challenge of Health Care in Europe: “value for money ”
description
Transcript of The Challenge of Health Care in Europe: “value for money ”
Professor Peter Littlejohns
BSc MBBS MD FRCP FFPH FRCGP
Clinical and Public Health Director
The Challenge of Health Care in Europe: “value for money”
Overview of presentation
(i) The challenge
(ii) NICE: brief history and emerging new role
(iii) A new research programme
Patient confidence that they will receive the most effective care
Opportunity costs
You can only spend one healthcare pound or euro once.
Within in a fixed budget if a health care system spends more on one thing, it has to do less of something else
The ‘opportunity cost’ is the value of the best alternative use of resources
“What is the most difficult ethical dilemma facing society and science today?”
Exchange recorded in The Guardian Weekend magazine 11 September 2010
How far do you go to preserve individual human life? I mean, what are we to do with the NHS? How can you put a value in pounds, shillings and pence on an individuals life? There was a case with a bowel cancer drug – if you gave that drug, which costs several thousand pounds, it continued life for six weeks. How can you make that decision?”
Sir David Attenborough, Naturalist
“Yes, that is a good one”
Richard Dawkins, Evolutionary biologist
Action at all levels of the system
The National Institute for Health and Clinical Excellence (NICE)
NICE is the independent organisation responsible for providing national guidance on the promotion of good health and the prevention and treatment of ill health. It was established in 1999 as a Special Authority and in 2005 it was expanded to include the functions of Health Development Agency. In 2012 (subject to legislation) it will become the National Institute for Health and Care Excellence and cover social care
• Public health – guidance on the promotion of good health and the prevention of ill health for those working in the NHS, local authorities and the wider public and voluntary sector
• Health technologies – guidance on the use of new and existing medicines, treatments and procedures within the NHS including interventional procedures, diagnostics and devices
• Clinical practice – guidance on the appropriate treatment and care of people with specific diseases and conditions within the NHS.
The Institute encourages cost effective practice by issuing guidance in three areas
Core principles underpinningall NICE guidance
• Comprehensive evidence base• Expert input• Patient and carer involvement• Independent advisory
committees• Genuine consultation• Regular review• Open and transparent process
William Blake – English Poet and Artist
“God forbid that truth should be confined to mathematical demonstration ”
NICE makes scientific and social values judgements
A short history of NICE
QOF
Public health
Interventional Procedures
Clinical guidelines
Quality standards
NICE’s new role in the NHS Outcomes Framework
NHS OUTCOMES FRAMEWORKDomain 1
Preventing people from
dying prematurely
Domain 2Enhancing the quality of life for
people with LTCs
Domain 3Recovery
from episodes of ill health /
injury
Domain 4Ensuring a
positive patient
experience
Domain 5Safe
environment free from avoidable
harm
NICE Quality Standards (Building a library of approx 150 over 5 years)
Commissioning Outcomes Framework
Commissioning Guidance
Provider payment mechanisms
Commissioning / ContractingNHS Commissioning Board - Specialist services and primary care
GP Consortia – all other services
1
2
3 4
7
Duty of quality
Du
ty o
f qu
ality
Du
ty o
f qu
ality
tariffstandard contract
CQUIN QOF
5
6
Duty of quality
NHS OUTCOMES FRAMEWORKDomain 1
Preventing people from
dying prematurely
Domain 2Enhancing the quality of life for
people with LTCs
Domain 3Recovery
from episodes of ill health /
injury
Domain 4Ensuring a
positive patient
experience
Domain 5Safe
environment free from avoidable
harm
NICE Quality Standards (Building a library of approx 150 over 5 years)
Commissioning Outcomes Framework
Commissioning Guidance
Provider payment mechanisms
Commissioning / ContractingNHS Commissioning Board - Specialist services and primary care
GP Consortia – all other services
1
2
3 4
7
Duty of quality
Du
ty o
f qu
ality
Du
ty o
f qu
ality
tariffstandard contract
CQUIN QOF
5
6
Duty of quality
Value Based Pricing
The UK Government view:
“We need a system that encourages the development of breakthrough drugs addressing areas of significant unmet need. And we need a much closer link between the price the NHS pays and the value a new medicine delivers, sending a powerful signal about the areas that the pharmaceutical industry should target for development.”
“Over the next three years we will be moving towards a new system of pricing for medicines, where the price of a drug will be determined by its assessed value.”
Kalipso Chalkidou
Working with Policy-Makers around the World
• Empowers decision makers in low and middle income countries by identifying and helping them to act on their own policy priorities
• Focuses on institutional structure, longer-term capacity building and system governance
• Offers collaborative problem-solving and hands-on support, drawing on people and experience, from the UK and abroad, to adapt evidence and policies to countries’ local context
Active or completed projects Exploring opportunities or strengthening institutional links
Thank you for your attention